Clinical Trial Update: Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program

View source ↗

Summary

Entecavir's Early Access Program for chronic hepatitis B has ended and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B, Chronic Disease | Status: NO_LONGER_AVAILABLE